genOway SA (ALGEN):企業の財務・戦略的SWOT分析

◆英語タイトル:genOway SA (ALGEN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2719
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

genOway SA (ALGEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

genOway SA (genOway) is a biotechnology company that develops genetically modified mouse, rat and cellular models for pharmaceutical companies and research institutes. The company develops several technology platforms such as safe DNA transgenesis, quick knock-in, safe in vivo RNAi and safe RNAi transgenesis. genOway provides access to its tool and consultancy services to its customers. It has a wide network of operations across Europe, Asia and North America. The company also has strategic alliances with few top pharmaceutical companies and leading research institutes. genOway is headquartered in Lyon, France.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
genOway SA – Key Facts 5
genOway SA – Key Employees 6
genOway SA – Key Employee Biographies 7
genOway SA – Major Products and Services 8
genOway SA – History 9
genOway SA – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
genOway SA – Business Description 14
genOway SA – SWOT Analysis 15
SWOT Analysis – Overview 15
genOway SA – Strengths 15
genOway SA – Weaknesses 16
genOway SA – Opportunities 17
genOway SA – Threats 18
genOway SA – Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios – Capital Market Ratios 20
Financial Ratios – Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
genOway SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
genOway SA, Recent Deals Summary 29
Section 5 – Appendix 30
Methodology 30
Ratio Definitions 30
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
genOway SA, Key Facts 5
genOway SA, Key Employees 6
genOway SA, Key Employee Biographies 7
genOway SA, Major Products and Services 8
genOway SA, History 9
genOway SA, Subsidiaries 12
genOway SA, Key Competitors 19
genOway SA, Ratios based on current share price 20
genOway SA, Annual Ratios 21
genOway SA, Annual Ratios (Cont...1) 22
genOway SA, Annual Ratios (Cont...2) 23
genOway SA, Interim Ratios 25
genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
genOway SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
genOway SA, Recent Deals Summary 29
Currency Codes 30
Capital Market Ratios 30
Equity Ratios 31
Profitability Ratios 31
Cost Ratios 32
Liquidity Ratios 32
Leverage Ratios 33
Efficiency Ratios 33

List of Figures
genOway SA, Performance Chart (2013 - 2017) 24
genOway SA, Ratio Charts 26
genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
genOway SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

★海外企業調査レポート[genOway SA (ALGEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Altus Power America Management LLC:電力:M&Aディール及び事業提携情報
    Summary Altus Power America Management LLC (Altus Power) is a renewable energy company that offers private investments in clean energy projects and renewable energy certificates. The company constructs, owns, operates and manages clean energy systems on commercial buildings and properties, schools a …
  • Bonterra Energy Corp (BNE)-石油・ガス分野:企業M&A・提携分析
    Summary Bonterra Energy Corp. (Bonterra) is an oil and gas company. It acquires and develops producing or undeveloped oil and gas properties. It produces crude oil, natural gas and natural gas liquids. The company principally operates in the provinces of Alberta, British Columbia and Saskatchewan in …
  • Cassa Depositi e Prestiti SpA:石油・ガス:M&Aディール及び事業提携情報
    Summary Cassa Depositi e Prestiti SpA (CDP) is a financial service provider that offers banking and financial services. The company offers loans to state and regional governments, public bodies, local authorities, and public-law entities through postal savings products under state guarantee and the …
  • Polaris Industries Inc (PII):企業の財務・戦略的SWOT分析
    Polaris Industries Inc (PII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Anthera Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Anthera Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anthera Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • CBS Corporation (CBS):企業の財務・戦略的SWOT分析
    CBS Corporation (CBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PPC Limited:企業の戦略・SWOT・財務情報
    PPC Limited - Strategy, SWOT and Corporate Finance Report Summary PPC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Entia Biosciences Inc (ERGO):企業の財務・戦略的SWOT分析
    Summary Entia Biosciences Inc (EBI) is a biotechnology company that provides nutrigenomics solutions for organic health, beauty and agriculture. The company’s solution includes ErgoD2, mushroom dietary supplement, and multi joint support. It offers ErgoD2 solutions such as Ergo-D2-Hemo, Ergo-D2-FLEX …
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • GliaCure Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary GliaCure Inc (GliaCure) is a developer of novel therapies for neurological and neuropsychiatric disorders. The company uses glia as an untapped resource for drug discovery, which controls the brain function in health and disease. It develops small molecule pharmaceuticals for the treatment o …
  • ToolGen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ToolGen Inc (ToolGen) is a genome editing company that concentrates on translating the genetic knowledge into transformative products for biomedicine and agriculture. The company creates intellectual property rights for essential tools and technologies for editing the genetic information in …
  • NATS Holdings Limited:企業の戦略・SWOT・財務情報
    NATS Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary NATS Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mahle GmbH:企業の戦略・SWOT・財務分析
    Mahle GmbH - Strategy, SWOT and Corporate Finance Report Summary Mahle GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Emlin Cosmetics:企業の戦略・SWOT・財務情報
    Emlin Cosmetics - Strategy, SWOT and Corporate Finance Report Summary Emlin Cosmetics - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • United Microelectronics Corporation (2303):企業の財務・戦略的SWOT分析
    United Microelectronics Corporation (2303) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • SNC-Lavalin Group Inc.:企業のM&A・事業提携・投資動向
    SNC-Lavalin Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SNC-Lavalin Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Saudi Industrial Export Company (4140):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Export Company (SIEC) is a chemical providing company that imports, exports and selss specialty chemicals, fertilizers, industrial materials and commodities. The company's fertilizers include diammonium phosphate, sulphur, urea, triple super phosphate, granular triple super …
  • The Allstate Corp:企業の戦略・SWOT・財務情報
    The Allstate Corp - Strategy, SWOT and Corporate Finance Report Summary The Allstate Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • AES Gener SA (AESGENER):企業の財務・戦略的SWOT分析
    AES Gener SA (AESGENER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Neovacs SA (ALNEV):企業の財務・戦略的SWOT分析
    Summary Neovacs SA (Neovacs) is a biotechnology company that develops various therapeutic vaccines for the treatment of autoimmune disorders, inflammatory diseases and cancers. The company offers TNF- kinoid and IFNalpha- kinoid products used for the treatment of rheumatoid arthritis, Crohn’s diseas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆